The use of bariatric or weight loss surgery has increased ten-fold in NHS hospitals in England since 2000, finds a study published on bmj.com. One reason for this rapid rise is increased demand from obese patients as they become more aware of surgery as a viable treatment option, suggest the researchers…

The number of NHS operations for bariatric or weight loss surgery has increased tenfold in England since 2000 say researchers, who suggest the main reason is because obese patients are more aware of it as a viable treatment option…

Ethicon Endo-Surgery (EES), has announced the introduction of a new addition to its HARMONIC(R) line of surgical devices, the HARMONIC ACE® 45 cm Curved Shears. HARMONIC ACE® 45 cm, designed to extend the reach of surgeons for minimally invasive procedures involving obese patients, is 25 percent longer (or 9cm) than the standard length HARMONIC ACE® device…

Orexigen® Therapeutics, Inc. (Nasdaq: OREX) announced the online publication of results from its COR-BMOD trial of Contrave® (naltrexone SR/bupropion SR) in the journal Obesity. The COR-BMOD trial evaluated intensive behavior modification (BMOD) plus Contrave32 (32mg naltrexone sustained release (SR)/360mg bupropion SR) compared to BMOD plus placebo, in 793 overweight or obese patients…

Hospitals are accommodating the increasing number of obese patients by buying larger medical equipment, The Milwaukee Journal Sentinel reports. The new purchases are “eating into capital budgets and driving growth in the plus-sized medical equipment market. …

Reuters - Overweight volunteers who took Orexigen’s experimental drug Contrave, designed to reduce cravings, lost about 13 pounds (6 kg) over a year, U.S. researchers reported on Thursday.

Subway riders walk through the turnstiles while leaving the U.S. Open in New York September 4, 2007. REUTERS/Lucas JacksonReuters - The first new prescription weight-loss pill in more than a decade failed to win backing from U.S. health advisers, who said safety concerns about the drug outweighed its ability to help obese patients shed pounds.

Obese and morbidly obese patients are at significantly greater risk of complications after a total hip reconstruction than non-obese patients, according to research published in the Medical Journal of Australia…

Ethicon Endo-Surgery, Inc. (EES), introduced a new addition to its HARMONIC® line of surgical devices, the HARMONIC ACE® 45 cm Curved Shears. HARMONIC ACE® 45 cm, designed to extend the reach of surgeons for minimally invasive procedures involving obese patients, is 25 percent longer (or 9cm) than the standard length HARMONIC ACE® device…

Surgeons at the University of Illinois at Chicago report the first successful robotic kidney transplant in a morbidly obese patient. The case study appears online in the American Journal of Transplantation. The patient, a 29-year-old woman with a body mass index of 41, had been on dialysis for five years while waiting for a deceased donor kidney…

Next Page →